Onset of vitiligo following targeted therapy for BRAF(V600E)-mutated melanoma: case report

Systemic treatment for metastatic melanoma has advanced dramatically in recent years with an impressive increase in the rate of overall survival. The two main different strategies are targeted therapies (i.e. BRAF and MEK inhibitors) and immunotherapy with monoclonal antibodies against the immune ch...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drugs Context
Autors principals: Brugnara, Sonia, Sicher, Mariacristina, Bonandini, Elena Maria, Barbareschi, Mattia, Girardelli, Carlo Renè, Caffo, Orazio
Format: Artigo
Idioma:Inglês
Publicat: BioExcel Publishing Ltd 2019
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7048152/
https://ncbi.nlm.nih.gov/pubmed/32158480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212582
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars